Silexion Therapeutics Corp (SLXN) concluded trading on Wednesday at a closing price of $1.45, with 84.74 million shares of worth about $122.87 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -88.96% during that period and on March 05, 2025 the price saw a gain of about 30.63%. Currently the company’s common shares owned by public are about 8.41M shares, out of which, 6.81M shares are available for trading.
Stock saw a price change of 26.09% in past 5 days and over the past one month there was a price change of -7.64%. Year-to-date (YTD), SLXN shares are showing a performance of -27.86% which decreased to -98.44% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.57 but also hit the highest price of $122.02 during that period. The average intraday trading volume for Silexion Therapeutics Corp shares is 13.12 million. The stock is currently trading 25.36% above its 20-day simple moving average (SMA20), while that difference is down -4.27% for SMA50 and it goes to -95.84% lower than SMA200.
Silexion Therapeutics Corp (NASDAQ: SLXN) currently have 8.41M outstanding shares and institutions hold larger chunk of about 7.03% of that.
The stock has a current market capitalization of $12.20M and its 3Y-monthly beta is at 0.08. It has posted earnings per share of -$19.71 in the same period. It has Quick Ratio of 0.85. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SLXN, volatility over the week remained 18.49% while standing at 20.69% over the month.
Analysts are in expectations that Silexion Therapeutics Corp (SLXN) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.
